Patents by Inventor Michael Thomas NGUYEN
Michael Thomas NGUYEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240345115Abstract: In one embodiment, a diagnostic system includes an instrument coupled to a client device and having at least one sample processing bay. The diagnostic system has a software architecture including instrument software (ISW) associated with the instrument. The ISW receives an assay definition file (ADF) that has a control file and an assay analysis module (AAM) file. The processing bay prepares and senses the sample according to parameters in the OPUS file and then generates sensor scan data. The diagnostic system then analyzes the sensor scan data and prepares a report according to the AAM file.Type: ApplicationFiled: April 29, 2024Publication date: October 17, 2024Applicant: Roche Molecular Systems, Inc.Inventors: Michael Thomas NGUYEN, Sean FORD, Nikolas James HANSEN
-
Patent number: 12000847Abstract: In one embodiment, a diagnostic system includes an instrument coupled to a client device and having at least one sample processing bay. The diagnostic system has a software architecture including instrument software (ISW) associated with the instrument. The ISW receives an assay definition file (ADF) that has a control file and an assay analysis module (AAM) file. The processing bay prepares and senses the sample according to parameters in the OPUS file and then generates sensor scan data. The diagnostic system then analyzes the sensor scan data and prepares a report according to the AAM file.Type: GrantFiled: March 2, 2022Date of Patent: June 4, 2024Assignee: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Michael Thomas Nguyen, Sean Ford, Nikolas James Hansen
-
Publication number: 20220381798Abstract: In one embodiment, a diagnostic system includes an instrument coupled to a client device and having at least one sample processing bay. The diagnostic system has a software architecture including instrument software (ISW) associated with the instrument. The ISW receives an assay definition file (ADF) that has a control file and an assay analysis module (AAM) file. The processing bay prepares and senses the sample according to parameters in the OPUS file and then generates sensor scan data. The diagnostic system then analyzes the sensor scan data and prepares a report according to the AAM file.Type: ApplicationFiled: March 2, 2022Publication date: December 1, 2022Applicant: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Michael Thomas NGUYEN, Sean FORD, Nikolas James HANSEN
-
Patent number: 11300578Abstract: In one embodiment, a diagnostic system includes an instrument coupled to a client device and having at least one sample processing bay. The diagnostic system has a software architecture including instrument software (ISW) associated with the instrument. The ISW receives an assay definition file (ADF) that has a control file and an assay analysis module (AAM) file. The processing bay prepares and senses the sample according to parameters in the OPUS file and then generates sensor scan data. The diagnostic system then analyzes the sensor scan data and prepares a report according to the AAM file.Type: GrantFiled: September 19, 2017Date of Patent: April 12, 2022Assignee: Roche Molecular Systems, Inc.Inventors: Michael Thomas Nguyen, Sean Ford, Nikolas James Hansen
-
Publication number: 20210246491Abstract: The present disclosure relates to methods and devices for amplifying a plurality of targets in a single PCR run while distinguishing between clinically relevant amplification and amplification from other sources such as from background contamination. The methods and devices further enable discrimination between gram-positive, gram-negative and fungal infections as wells as identify antimicrobial resistance genes. When applying the methods and devices of the invention, the species or genus of an infection(s), and genus of a fungal co-infection(s) or category of bacterial (gram-positive or negative) co-infection(s) are identified. Species identification of co-infections can also be achieved. Further, when applying the methods and devices of the invention, organisms which are likely to be contaminating organisms from a blood draw are identified.Type: ApplicationFiled: April 28, 2021Publication date: August 12, 2021Applicant: Clinical Micro Sensors, Inc. (dba GenMark Diagnostics, Inc.)Inventors: Lisa Lynn Freeman-Cook, Christine J. Shaw, Milena Iacobelli Martinez, Anna Maria Al-Khouri, Bradley Adam Brown, John Jay Harvey, Michael Thomas Nguyen
-
Publication number: 20210181219Abstract: A pathogen detection device is provided. The pathogen detection device may include a pathogen detector circuit configured to detect a target analyte in a patient sample, determine the presence of a pathogen from the target analyte, and generate a detection result including the identity of the pathogen and resistance genes (if any); and a decision support generator circuit configured to generate decision support information for the pathogen by application of user configurable rules to the detection result, wherein each of the configurable rules include a logic expression that indicates the corresponding decision support information of the rule to be included in the detection report.Type: ApplicationFiled: January 26, 2021Publication date: June 17, 2021Applicant: GenMark Diagnostics, Inc.Inventors: Michael Thomas Nguyen, Margaret Ginzburg, Shawn Andre Hall, Lisa M. Filippone
-
Patent number: 11021759Abstract: The present disclosure relates to methods and devices for amplifying a plurality of targets in a single PCR run while distinguishing between clinically relevant amplification and amplification from other sources such as from background contamination. The methods and devices further enable discrimination between gram-positive, gram-negative and fungal infections as wells as identify antimicrobial resistance genes. When applying the methods and devices of the invention, the species or genus of an infection(s), and genus of a fungal co-infection(s) or category of bacterial (gram-positive or negative) co-infection(s) are identified. Species identification of co-infections can also be achieved. Further, when applying the methods and devices of the invention, organisms which are likely to be contaminating organisms from a blood draw are identified.Type: GrantFiled: April 24, 2020Date of Patent: June 1, 2021Assignee: Clinical Micro Sensors, Inc.Inventors: Lisa Lynn Freeman-Cook, Christine J. Shaw, Milena Iacobelli Martinez, Anna Maria Al-Khouri, Bradley Adam Brown, John Jay Harvey, Michael Thomas Nguyen
-
Patent number: 10935561Abstract: A pathogen detection device is provided. The pathogen detection device may include a pathogen detector circuit configured to detect a target analyte in a patient sample, determine the presence of a pathogen from the target analyte, and generate a detection result including the identity of the pathogen and resistance genes (if any); and a decision support generator circuit configured to generate decision support information for the pathogen by application of user configurable rules to the detection result, wherein each of the configurable rules include a logic expression that indicates the corresponding decision support information of the rule to be included in the detection report.Type: GrantFiled: June 1, 2018Date of Patent: March 2, 2021Assignee: GenMark Diagnostics, Inc.Inventors: Michael Thomas Nguyen, Margaret Ginzburg, Shawn Andre Hall, Lisa M. Filippone
-
Publication number: 20190369126Abstract: A pathogen detection device is provided. The pathogen detection device may include a pathogen detector circuit configured to detect a target analyte in a patient sample, determine the presence of a pathogen from the target analyte, and generate a detection result including the identity of the pathogen and resistance genes (if any); and a decision support generator circuit configured to generate decision support information for the pathogen by application of user configurable rules to the detection result, wherein each of the configurable rules include a logic expression that indicates the corresponding decision support information of the rule to be included in the detection report.Type: ApplicationFiled: June 1, 2018Publication date: December 5, 2019Applicant: GenMark Diagnostics, Inc.Inventors: Michael Thomas Nguyen, Margaret Ginzburg, Shawn Andre Hall, Lisa M. Filippone
-
Publication number: 20180095100Abstract: In one embodiment, a diagnostic system includes an instrument coupled to a client device and having at least one sample processing bay. The diagnostic system has a software architecture including instrument software (ISW) associated with the instrument. The ISW receives an assay definition file (ADF) that has a control file and an assay analysis module (AAM) file. The processing bay prepares and senses the sample according to parameters in the OPUS file and then generates sensor scan data. The diagnostic system then analyzes the sensor scan data and prepares a report according to the AAM file.Type: ApplicationFiled: September 19, 2017Publication date: April 5, 2018Applicant: GENMARK DIAGNOSTICS, INC.Inventors: Michael Thomas NGUYEN, Sean FORD, Nikolas James HANSEN